IL-1β Is Involved with the Generation of Pain in Experimental Autoimmune Encephalomyelitis

Molecular Neurobiology

Volumn 53, Issue 9, 2016, Pages 6540-6547

  Rodrigues, David Henrique ^a,b   Leles, Bruno Pereira ^b   Costa, Vivian Vasconcelos ^b   Miranda, Aline Silva ^b   Cisalpino, Daniel ^b   Gomes, Dawidson Assis ^b   de Souza, Danielle Glória ^b   Teixeira, Antônio Lúcio ^b  

^a FEDERAL UNIVERSITY OF JUIZ DE FORA   (Brazil)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Cytokines; Dorsal root ganglia; Experimental autoimmune encephalomyelitis; Hypernociception

Indexed keywords

FREUND ADJUVANT; INFLIXIMAB; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; NEUROTROPHIC FACTOR; TUMOR NECROSIS FACTOR; CXCL1 CHEMOKINE; CXCL1 PROTEIN, MOUSE; MESSENGER RNA; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; SCN10A PROTEIN, MOUSE; SODIUM CHANNEL NAV1.8; TRPV1 PROTEIN, MOUSE; VANILLOID RECEPTOR;

ALLODYNIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; FEMALE; FORCE TRANSDUCER; FRONTAL CORTEX; HIPPOCAMPUS; HYPERALGESIA; IMMUNOPHARMACOLOGY; MOUSE; MULTIPLE SCLEROSIS; NOCICEPTION; NONHUMAN; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SPINAL GANGLION; ANIMAL; C57BL MOUSE; COMPLICATION; GENETICS; METABOLISM; PAIN; PATHOLOGY; PATHOPHYSIOLOGY; SPINAL CORD;

ANIMALS; CHEMOKINE CXCL1; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; GANGLIA, SPINAL; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-1BETA; MICE, INBRED C57BL; MYELIN-OLIGODENDROCYTE GLYCOPROTEIN; NAV1.8 VOLTAGE-GATED SODIUM CHANNEL; NOCICEPTION; PAIN; RNA, MESSENGER; SPINAL CORD; TRPV CATION CHANNELS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84948672742     PISSN: 08937648     EISSN: 15591182     Source Type: Journal    
DOI: 10.1007/s12035-015-9552-0     Document Type: Article

References (35)

1. McFarland HF, Martin R (2007) Multiple sclerosis: a complicated picture of autoimmunity. Nat Immunol 8(9):913–919
2. Siniscalchi A, Gallelli L, De Sarro G (2007) Drugs treatment of pain in multiple sclerosis. Curr Clin Pharmacol 2(3):227–233
3. Beard S, Hunn A, Wight J (2003) Treatments for spasticity and pain in multiple sclerosis: a systematic review. Health Technol Assess 7:1–124
4. Foley PL, Vesterinen HM, Laird BJ, Sena ES, Colvin LA, Chandran S, MacLeod MR, Fallon MT (2013) Prevalence and natural history of pain in adults with multiple sclerosis: systematic review and meta-analysis. Pain 154(5):632–642
5. O’Connor AB et al (2008) Pain associated with multiple sclerosis: systematic review and proposed classification. Pain 137:96–111
6. Gold R, Linington C, Lassmann H (2006) Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research. Brain 129:1953–1971
7. Bettelli E, Oukka M, Kuchroo VK (2007) T(H)-17 cells in the circle of immunity and autoimmunity. Nat Immunol 8:345–350
8. Dos Santos AC, Roffê E, Arantes RM, Juliano L, Pesquero JL, Pesquero JB, Bader M, Teixeira MM et al (2008) Kinin B2 receptor regulates chemokines CCL2 and CCL5 expression and modulates leukocyte recruitment and pathology in experimental autoimmune encephalomyelitis (EAE) in mice. J Neuroinflammation 5:49
9. Grace PM, Hutchinson MR, Maier SF, Watkins LR (2014) Pathological pain and the neuroimmune interface. Nat Rev Immunol 14(4):217–231
10. Sean Riminton D, Körner H, Strickland DH, Lemckert FA, Pollard JD, Sedgwick JD (1998) Challenging cytokine redundancy: inflammatory cell movement and clinical course of experimental autoimmune encephalomyelitis are normal in lymphotoxin-deficient, but not tumor necrosis factor-deficient, mice. J Exp Med 187(9):1517–1528
11. Schiffenbauer J, Streit WJ, Butfiloski E, LaBow M, Edwards C 3rd, Moldawer LL (2000) The induction of EAE is only partially dependent on TNF receptor signaling but requires the IL-1 type I receptor. Clin Immunol 95(2):117–123
12. Cunha TM, Verri WA Jr, Valério DA, Guerrero AT, Nogueira LG, Vieira SM, Souza DG, Teixeira MM et al (2008) Role of cytokines in mediating mechanical hypernociception in a model of delayed-type hypersensitivity in mice. Eur J Pain 12(8):1059–1068
13. Begum F, Zhu W, Cortes C, MacNeil B, Namaka M (2013) Elevation of tumor necrosis factor α in dorsal root ganglia and spinal cord is associated with neuroimmune modulation of pain in an animal model of multiple sclerosis. J Neuroimmune Pharmacol 8(3):677–690
14. Thibault K, Calvino B, Pezet S (2011) Characterisation of sensory abnormalities observed in an animal model of multiple sclerosis: a behavioural and pharmacological study. Eur J Pain 15(3):231.e1-16
15. Rodrigues DH, Sachs D, Teixeira AL (2009) Mechanical hypernociception in experimental autoimmune encephalomyelitis. Arq Neuropsiquiatr 67(1):78–81
16. Olechowski CJ, Truong JJ, Kerr BJ (2009) Neuropathic pain behaviours in a chronic-relapsing model of experimental autoimmune encephalomyelitis (EAE). Pain 141(1–2):156–164
17. Aicher SA, Silverman MB, Winkler CW, Bebo BF Jr (2004) Hyperalgesia in an animal model of multiple sclerosis. Pain 110(3):560–570
18. Weaver A, Silva AG, Nuttall RK et al (2005) An elevated matrix metalloproteinase (MMP) in an animal model of multiple sclerosis is protective by affecting Th1/Th2 polarization. FASEB J 19:1668–1670
19. Brundula V, Rewcastle NB, Metz LM, Bernard CC, Yong VW (2002) Targeting leukocyte MMPs and transmigration: minocycline as a potential therapy for multiple sclerosis. Brain 125:1297–1308
20. Coelho FM, Pinho V, Amaral FA et al (2008) The chemokine receptors CXCR1/2 modulate antigen-induced arthritis by regulating adhesion of neutrophils to the synovial microvasculature. Arthritis Rheum 58:2329–2337
21. Dos Santos AC, Roffê E, Arantes RM, Juliano L, Pesquero JL, Pesquero JB, Bader M, Teixeira MM et al (2008) Kinin B2 receptor regulates chemokines CCL2 and CCL5 expression and modulates leukocyte recruitment and pathology in experimental autoimmune encephalomyelitis (EAE) in mice. J Neuroinflammation 5:5–49
22. Rodrigues DH, Vilela MC, Barcelos LS, Pinho V, Teixeira MM, Teixeira AL (2010) Absence of PI3Kgamma leads to increased leukocyte apoptosis and diminished severity of experimental autoimmune encephalomyelitis. J Neuroimmunol 222(1–2):90–94
23. Galic MA, Riazi K, Pittman QJ (2012) Cytokines and brain excitability. Front Neuroendocrinol 33(1):116–125
24. Wang J, Yu J, Ding CP, Han SP, Zeng XY, Wang JY (2015) Transforming growth factor-beta in the red nucleus plays antinociceptive effect under physiological and pathological pain conditions. Neuroscience 291:37–45
25. Sloane E, Ledeboer A, Seibert W, Coats B, van Strien M, Maier SF, Johnson KW, Chavez R et al (2009) Anti-inflammatory cytokine gene therapy decreases sensory and motor dysfunction in experimental multiple sclerosis: MOG-EAE behavioral and anatomical symptom treatment with cytokine gene therapy. Brain Behav Immun 23(1):92–100
26. Lisi L, Navarra P, Cirocchi R, Sharp A, Stigliano E, Feinstein DL, Dello Russo C (2012) Rapamycin reduces clinical signs and neuropathic pain in a chronic model of experimental autoimmune encephalomyelitis. J Neuroimmunol 243(1–2):43–51
27. Melanson M, Miao P, Eisenstat D, Gong Y, Gu X, Au K, Zhu W, Begum F et al (2009) Experimental autoimmune encephalomyelitis-induced upregulation of tumor necrosis factor-alpha in the dorsal root ganglia. Mult Scler 15(10):1135–1145
28. Matsuki T, Nakae S, Sudo K, Horai R, Iwakura Y (2006) Abnormal T cell activation caused by the imbalance of the IL-1/IL-1R antagonist system is responsible for the development of experimental autoimmune encephalomyelitis. Int Immunol 18(2):399–407
29. Sim YB, Park SH, Kang YJ, Jung JS, Ryu OH, Choi MG, Suh HW (2012) Interleukin-1β (IL-1β) increases pain behavior and the blood glucose level: possible involvement of sympathetic nervous system. Pharmacol Biochem Behav 102(1):170–176
30. Binshtok AM, Wang H, Zimmermann K, Amaya F, Vardeh D, Shi L, Brenner GJ, Ji RR et al (2008) Nociceptors are interleukin-1beta sensors. J Neurosci 28:14062–14073
31. Caterina MJ, Leffler A, Malmberg AB, Martin WJ, Trafton J, Petersen-Zeitz KR, Koltzenburg M, Basbaum AI et al (2000) Impaired nociception and pain sensation in mice lacking the capsaicin receptor. Science 14 288(5464):306–313
32. Cummins TR, Sheets PL, Waxman SG (2007) The roles of sodium channels in nociception: implications for mechanisms of pain. Pain 131(3):243–257
33. Hwang SW, Cho H, Kwak J, Lee SY, Kang CJ, Jung J, Cho S, Min KH et al (2000) Direct activation of capsaicin receptors by products of lipoxygenases: endogenous capsaicin-like substances. Proc Natl Acad Sci U S A 97(11):6155–6160
34. Ji RR, Samad TA, Jin SX, Schmoll R, Woolf CJ (2002) p38 MAPK activation by NGF in primary sensory neurons after inflammation increases TRPV1 levels and maintains heat hyperalgesia. Neuron 36(1):57–68
35. Jarvis MF, Honore P, Shieh CC et al (2007) A-803467, a potent and selective Nav1.8 sodium channel blocker, attenuates neuropathic and inflammatory pain in the rat. Proc Natl Acad Sci U S A 104(20):8520–8525